Page last updated: 2024-08-21

carvacrol and Atherosclerotic Parkinsonism

carvacrol has been researched along with Atherosclerotic Parkinsonism in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Azizi, Z; Farhadi, M; Manouchehrabadi, M; Torkaman-Boutorabi, A	1

Other Studies

1 other study(ies) available for carvacrol and Atherosclerotic Parkinsonism

Article	Year
Carvacrol Protects Against 6-Hydroxydopamine-Induced Neurotoxicity in In Vivo and In Vitro Models of Parkinson's Disease. Neurotoxicity research, 2020, Volume: 37, Issue:1 Topics: Animals; Annexins; Behavior, Animal; Cell Survival; Corpus Striatum; Cymenes; Dose-Response Relationship, Drug; Glutathione; Lipid Peroxidation; Male; Malondialdehyde; Nerve Degeneration; Neuroprotective Agents; Oxidopamine; Parkinson Disease, Secondary; PC12 Cells; Rats; Reactive Oxygen Species	2020

Article

Year

Carvacrol Protects Against 6-Hydroxydopamine-Induced Neurotoxicity in In Vivo and In Vitro Models of Parkinson's Disease.

Neurotoxicity research, 2020, Volume: 37, Issue:1

Topics: Animals; Annexins; Behavior, Animal; Cell Survival; Corpus Striatum; Cymenes; Dose-Response Relationship, Drug; Glutathione; Lipid Peroxidation; Male; Malondialdehyde; Nerve Degeneration; Neuroprotective Agents; Oxidopamine; Parkinson Disease, Secondary; PC12 Cells; Rats; Reactive Oxygen Species

2020